These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20814717)

  • 1. Trainable structure-activity relationship model for virtual screening of CYP3A4 inhibition.
    Didziapetris R; Dapkunas J; Sazonovas A; Japertas P
    J Comput Aided Mol Des; 2010 Nov; 24(11):891-906. PubMed ID: 20814717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neural network based virtual screening of cytochrome P450 3A4 inhibitors.
    Molnar L; Keseru GM
    Bioorg Med Chem Lett; 2002 Feb; 12(3):419-21. PubMed ID: 11814811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of CYP3A4 inhibition models: comparisons of machine-learning techniques and molecular descriptors.
    Arimoto R; Prasad MA; Gifford EM
    J Biomol Screen; 2005 Apr; 10(3):197-205. PubMed ID: 15809315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening.
    Hsieh JH; Wang XS; Teotico D; Golbraikh A; Tropsha A
    J Comput Aided Mol Des; 2008 Sep; 22(9):593-609. PubMed ID: 18338225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probabilistic prediction of the human CYP3A4 and CYP2D6 metabolism sites.
    Dapkunas J; Sazonovas A; Japertas P
    Chem Biodivers; 2009 Nov; 6(11):2101-6. PubMed ID: 19937844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios.
    Hristozov DP; Oprea TI; Gasteiger J
    J Comput Aided Mol Des; 2007; 21(10-11):617-40. PubMed ID: 18008169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance?
    Pérez-Castillo Y; Cruz-Monteagudo M; Lazar C; Taminau J; Froeyen M; Cabrera-Pérez MA; Nowé A
    Mol Divers; 2014 Aug; 18(3):637-54. PubMed ID: 24671521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR modeling of in vitro inhibition of cytochrome P450 3A4.
    Mao B; Gozalbes R; Barbosa F; Migeon J; Merrick S; Kamm K; Wong E; Costales C; Shi W; Wu C; Froloff N
    J Chem Inf Model; 2006; 46(5):2125-34. PubMed ID: 16995743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
    Roy K; Pratim Roy P
    Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
    Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
    Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors.
    Jensen BF; Vind C; Padkjaer SB; Brockhoff PB; Refsgaard HH
    J Med Chem; 2007 Feb; 50(3):501-11. PubMed ID: 17266202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening.
    Xia G; Xue M; Liu L; Yu J; Liu H; Li P; Wang J; Li Y; Xiong B; Shen J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5739-44. PubMed ID: 21873057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recursive partitioning for the prediction of cytochromes P450 2D6 and 1A2 inhibition: importance of the quality of the dataset.
    Burton J; Ijjaali I; Barberan O; Petitet F; Vercauteren DP; Michel A
    J Med Chem; 2006 Oct; 49(21):6231-40. PubMed ID: 17034129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and validation of rapid computational filters for cyp2d6 and cyp3a4.
    Ekins S; Berbaum J; Harrison RK
    Drug Metab Dispos; 2003 Sep; 31(9):1077-80. PubMed ID: 12920160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
    Brown HS; Galetin A; Hallifax D; Houston JB
    Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition.
    Susnow RG; Dixon SL
    J Chem Inf Comput Sci; 2003; 43(4):1308-15. PubMed ID: 12870924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graph wavelet alignment kernels for drug virtual screening.
    Smalter A; Huan J; Lushington G
    J Bioinform Comput Biol; 2009 Jun; 7(3):473-97. PubMed ID: 19507286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consideration of molecular weight during compound selection in virtual target-based database screening.
    Pan Y; Huang N; Cho S; MacKerell AD
    J Chem Inf Comput Sci; 2003; 43(1):267-72. PubMed ID: 12546562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IC50-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4.
    Burt HJ; Galetin A; Houston JB
    Xenobiotica; 2010 May; 40(5):331-43. PubMed ID: 20230210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.